A kind of Parkinson's related biomarker and its application
A Parkinson's disease and drug technology, applied in the field of Parkinson's related biomarkers and biomarkers, can solve the problem that neuroprotective agents cannot effectively improve PD symptoms, etc.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0046] Example 1 Screening for gene markers associated with Parkinson's disease
[0047] 1. Sample collection
[0048] Collect 10 normal blood samples and blood samples from patients with Parkinson's disease, and write down the sample name, serial number, sampling date, sample processing process, etc. All the above-mentioned samples were obtained with the approval of the ethics committee.
[0049] 2. Preparation of RNA samples
[0050] RNA samples were extracted using Invitrogen's Blood RNA Extraction Kit. For details, see the instruction manual.
[0051] 3. Quality analysis of RNA samples
[0052] The above-mentioned extracted RNA was subjected to agarose gel electrophoresis, and the concentration and purity of the extracted RNA were detected by Nanodrop2000, the RNA integrity was detected by agarose gel electrophoresis, and the RIN value was determined by Agilent2100. The total amount of RNA required for a single library construction is 5ug, the concentration is ≥200ng / μL...
Embodiment 2
[0063] Example 2 QPCR sequencing to verify the differential expression of the FGFBP2 gene
[0064] 1. According to the detection results of high-throughput sequencing, the FGFBP2 gene was selected for large-sample QPCR verification. According to the sample collection method in Example 1, 90 cases of blood from Parkinson's patients and 90 cases of normal blood were selected.
[0065] 2. The RNA extraction steps are the same as in Example 1.
[0066] 3. Reverse transcription:
[0067] (1) Take 2 μg of total RNA for reverse transcription, add 2 μl of Oligo(dT), and mix well. After 5 minutes in water bath at 70°C, immediately ice bath for 2-3 minutes.
[0068] (2) Construct a 25 μl reaction system, including 5 μl of 5× reverse transcription buffer, 5 μl of dNTP (2.5 mM), 40 U / μl of RNasin, 200 U / μl of M-MLV, and make up to the expected volume with nuclease-free water.
[0069] (3) After 60 minutes of water bathing at 42° C., then 5 minutes of water bathing at 95° C. to inactiv...
Embodiment 3
[0090] Example 3 Silencing of FGFBP2 Gene
[0091] 1. Cell culture
[0092] Dopamine neuronal cells SH-SY5Y were prepared in DMEM medium containing 10% fetal bovine serum and 1% penicillin / streptomycin (pH 7.2-7.4), at 37°C and 5% CO 2 , Cultivated in an incubator with a relative humidity of 90%. Change the medium once every 2 days, and subculture when the cells grow to 90% contact. After washing with PBS, add 0.25%-EDTA trypsin to separate the cells from the bottle wall, and terminate with DMEM medium containing fetal bovine serum. Trypsin digestion reaction, centrifuged at 1000g for 2min, discarded the supernatant, resuspended with the newly prepared culture medium, and passaged at a ratio of 1:3 to 1:4. After 24 hours, the cells entered the logarithmic growth phase and replaced the culture medium according to the experimental requirements. give different interventions.
[0093] 2. siRNA design
[0094] siRNA sequences against FGFBP2:
[0095] siRNA1:
[0096] The sens...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com